Optimising cardiovascular risk management early in the diabetes disease trajectory

Type 2 diabetes increases an individual’s risk of Cardiovascular Disease (CVD). Trials have demonstrated the long term macro-vascular benefits of lowering glucose, as well as other CVD risk factors, in populations with established diabetes.

Effect of early intensive multifactorial therapy on modelled coronary heart disease risk in individuals with diabetes detected by screening: ADDITION-Europe, a randomised trial

Quality of life after injury : an IPD meta-analysis

Purpose There is a need for information on the Health Related Quality of Life (HRQoL) of injury populations. HRQoL measures, like the EQ-5D, have seen a dramatic increase in use over the last ten years. Despite this, general information on HRQoL …